Drugs / Glycolic acid tetrasubstituted piceatannol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06127381 | Nov 2023 → Apr 2024 | acute respiratory distress syndrome | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glycolic acid tetrasubstituted piceatannol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06127381 ↗ |
| Known as | TGKP | “Glycolic acid tetrasubstituted piceatannol (TGKP)” NCT06127381 ↗ |
| Route | Intravenous | “single intravenous administration” NCT06127381 ↗ |